Morgan Stanley’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.2M | Buy |
576,372
+54,018
| +10% | +$3.11M | ﹤0.01% | 2300 |
|
|
2025
Q1 | $30.4M | Sell |
522,354
-235,046
| -31% | -$13.7M | ﹤0.01% | 2277 |
|
|
2024
Q4 | $61M | Buy |
757,400
+106,627
| +16% | +$8.59M | ﹤0.01% | 1657 |
|
|
2024
Q3 | $52.1M | Buy |
650,773
+82,268
| +14% | +$6.59M | ﹤0.01% | 1789 |
|
|
2024
Q2 | $34.7M | Buy |
568,505
+262,338
| +86% | +$16M | ﹤0.01% | 2102 |
|
|
2024
Q1 | $15.1M | Sell |
306,167
-112,679
| -27% | -$5.57M | ﹤0.01% | 2980 |
|
|
2023
Q4 | $17.6M | Buy |
418,846
+330,057
| +372% | +$13.8M | ﹤0.01% | 3460 |
|
|
2023
Q3 | $2.91M | Sell |
88,789
-34,981
| -28% | -$1.15M | ﹤0.01% | 4122 |
|
|
2023
Q2 | $4.38M | Sell |
123,770
-14,559
| -11% | -$515K | ﹤0.01% | 3876 |
|
|
2023
Q1 | $3.93M | Sell |
138,329
-6,568
| -5% | -$187K | ﹤0.01% | 3969 |
|
|
2022
Q4 | $6.02M | Buy |
144,897
+61,610
| +74% | +$2.56M | ﹤0.01% | 3587 |
|
|
2022
Q3 | $3.45M | Buy |
83,287
+26,461
| +47% | +$1.1M | ﹤0.01% | 3987 |
|
|
2022
Q2 | $1.86M | Sell |
56,826
-6,753
| -11% | -$221K | ﹤0.01% | 4591 |
|
|
2022
Q1 | $2.22M | Buy |
63,579
+24,706
| +64% | +$864K | ﹤0.01% | 4436 |
|
|
2021
Q4 | $973K | Buy |
38,873
+38,673
| +19,337% | +$968K | ﹤0.01% | 5088 |
|
|
2021
Q3 | $8K | Buy |
+200
| New | +$8K | ﹤0.01% | 7397 |
|